Table 1 Ku80 expression of lung cancer detected by immunohistochemistry
Feature | patients (n = 110) | Ku80 protein level | p | |
|---|---|---|---|---|
positive (n = 76) | negative (n = 34) | |||
Age at diagnosis | ||||
≤ 60 | 66 (60%) | 50 (65.8%) | 16 (47.1%) | 0.09 |
> 60 | 44 (40%) | 26 (34.2%) | 18 (52.9%) | |
Gender | ||||
Male | 32 (29.1%) | 24 (31.6%) | 8 (23.5%) | 0.50 |
Female | 78 (70.9%) | 52 (68.4%) | 26 (76.5%) | |
Smoking status | ||||
Never | 71 (64.5%) | 50 (65.8%) | 21 (61.8%) | 0.68 |
Former or current smokers | 39 (35.4) | 26 (34.2) | 13 (38.2%) | |
Stage(T) | ||||
T1-2 | 58 (52.7%) | 30 (39.5%) | 28 (82.4%) | 0.00 |
T3-4 | 52 (47.2%) | 46 (60.5%) | 6 (17.6%) | |
Lymph node metastasis | ||||
N0-1 | 47 (42.7%) | 22 (28.9%) | 25 (73.5%) | 0.00 |
N2 | 63 (57.2%) | 54 (71.1%) | 9 (26.5%) | |
Response to chemotherapy | ||||
(+) | 38 (34.5%) | 7 (9.2%) | 31 (91.2%) | 0.00 |
(-) | 72 (65.5%) | 69 (90.8%) | 3 (8.8%) | |